Health equity: A framework for the epidemiology of care

 ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌  ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌  ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌  ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌  ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌  ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌  ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌  ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌  ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌  ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌  ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌  ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ .
McKinsey & Company
Share this email LinkedIn Twitter Facebook
Daily Read
AN ARTICLE A DAY, PICKED BY OUR EDITORS
Better healthcare is an absolute good. But whose health concerns have we been solving for? The analysis changes as we think through an equity lens. Indeed, health inequities manifest in a variety of ways: limited access to food, care, or medication; unmet needs, when innovation is misaligned with disease burdens; or underserved communities, when key actors fail to engage groups commensurate with their needs. Addressing the issues has obvious benefits for patients—and the pharmaceutical and life sciences companies that serve them. A new article outlines a framework to approach health equity, recognize its limits, and sharpen decision making. Don’t miss it.
— Torea Frey, managing editor, Seattle
Urban crowd of people from above
 
Health equity: A framework for the epidemiology of care
Pharmaceutical and life sciences companies can unlock new opportunities, help underserved patients, and build a cycle of trust.
Understand the issues  
Quote
Quote of the Day
“Action to achieve sociocultural diversity—closely overseen by top management—must be part of a transformation project for the company as a whole. ... The mobilization of the management team and the whole organization must be strong and visible, both to employees and to external stakeholders such as consumers, investors, the media, and the general public.”
—See what organizations can do to promote sociocultural-diversity initiatives in “Beyond gender: Promoting diversity in French companies
Chart of the Day
chart of the day
See today's chart  
Also New
Damaged wall surface after hit
War in Ukraine: Lives and livelihoods, lost and disrupted
As uncertainty weighs on decision making, scenarios can provide guidance.
Understand the implications   >
phone
Germany's e-health transformation makes uneven progress
Our eHealth Monitor report shows solid uptakes of telemedicine and consumer health apps. But e-prescriptions, health data exchange, and patient use of electronic health records are lagging behind.
Understand the trends   >
Building next-generation B2B sales capabilities
Building next-generation B2B sales capabilities
The pandemic has converted B2B buyers to e-commerce in a big way. B2B sellers need new capabilities to meet their new expectations.
Deliver outperformance  >
McKinsey & Company
Follow our thinking
LinkedIn Twitter Facebook
Share these insights
Did you enjoy this newsletter? Forward it to colleagues and friends so they can subscribe too.
Was this issue forwarded to you? Sign up for it and sample our 40+ other free email subscriptions here.
This email contains information about McKinsey’s research, insights, services, or events. By opening our emails or clicking on links, you agree to our use of cookies and web tracking technology. For more information on how we use and protect your information, please review our privacy policy.
You received this email because you subscribed to the Daily Read newsletter.
Manage subscriptions | Unsubscribe
Copyright © 2022 | McKinsey & Company, 3 World Trade Center, 175 Greenwich Street, New York, NY 10007
                                                           

No comments: